Illumina reports preliminary Q4 revenue of $1.15B
Source: SeekingAlpha
2026-01-13 09:20:26 ET
More on Illumina
- Illumina, Inc. (ILMN) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript
- Illumina: An Excellent Profit Margin And The Sequencing Genome Market Will Unlock Value
- Illumina names former NIH official as medical chief; commercial chief joins Quanterix
- LLY joins $1T club but doesn't feature in SA's top 10 large-cap healthcare stocks
Read the full article on Seeking Alpha
For further details see:
Illumina reports preliminary Q4 revenue of $1.15B
Illumina Inc.
NASDAQ: ILMN
ILMN Trading
0.93% G/L:
$119.365 Last:
761,771 Volume:
$116.10 Open:
ILMN Latest News
March 05, 2026 09:15:00 am
Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering
February 27, 2026 09:15:00 am
Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida
February 25, 2026 09:15:00 am
Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics
February 24, 2026 12:15:00 pm
Illumina launches TruPath Genome, setting a new standard in genomic insight
ILMN Stock Data
$18,085,408,000
148,827,200
0.13%
404
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
